3rd Quarter - Report

MAYER BROWN LLP for NOVOCURE

Firm
Client
Income
$10,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Issues related to Section 232 investigations.

LobbyistCovered position, as disclosed
DANIEL HARDER —
WARREN PAYNE —

Contacted: U.S. Trade Representative (USTR); SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.